Salactol Collodion
*Company:
Dermal Laboratories (Ireland) LtdStatus:
UpdatedLegal Category:
Supply through pharmacy onlyActive Ingredient(s):
*Additional information is available within the SPC or upon request to the company
Updated on 26 November 2024
File name
SLTL-IPHA-PIL.pdf
Reasons for updating
- Change to section 4 - how to report a side effect
- Change to section 6 - marketing authorisation number
- Change to section 6 - date of revision
Free text change information supplied by the pharmaceutical company
Section 4 revised wording remove yellow card details add Via HPRA Pharmacovigilance website, add Via HPRA Pharmacovigilance website WWW.hpra.ie
Section 6 Marketing Authorisation delete UK details
Section 6 leaflet revised September 2024
Updated on 26 November 2024
File name
SLTL-IPHA-SPC.pdf
Reasons for updating
- Change to Section 4.8 – Undesirable effects - how to report a side effect
- Change to section 10 - Date of revision of the text
Legal category:Supply through pharmacy only
Free text change information supplied by the pharmaceutical company
In Section 4.8 Undesirable effects
The following text has been revised :
After Pharmacovigilance, IR address deleted and email removed
In Section 10 Date of revision of the text:
The date has changed to:
“November 2024”
Updated on 23 January 2023
File name
SLTL-IPHA.SPC.pdf
Reasons for updating
- Document format updated
Legal category:Supply through pharmacy only
Updated on 17 December 2020
File name
SLTL-IPHA.SPC.pdf
Reasons for updating
- Change to section 7 - Marketing authorisation holder
- Change to section 8 - Marketing authorisation number(s)
- Change to section 10 - Date of revision of the text
Legal category:Supply through pharmacy only
Updated on 31 August 2018
File name
SLTL-IPHA.SPC.07.07.15.10.07.15.pdf
Reasons for updating
- File format updated to PDF
Legal category:Supply through pharmacy only
Free text change information supplied by the pharmaceutical company
File format updated to PDF
Updated on 10 July 2015
File name
PIL_8667_951.pdf
Reasons for updating
- New PIL for new product
Updated on 10 July 2015
Reasons for updating
- New SPC for new product
Legal category:Supply through pharmacy only
Updated on 10 July 2015
Reasons for updating
- Change to Section 4.8 – Undesirable effects - how to report a side effect
- Change to section 10 - Date of revision of the text
- Improved electronic presentation
Legal category:Supply through pharmacy only
Free text change information supplied by the pharmaceutical company
Reporting of suspected adverse reactions
Reporting suspected adverse reactions after authorisation of the medicinal product is important. It allows continued monitoring of the benefit/risk balance of the medicinal product. Healthcare professionals are asked to report any suspected adverse reactions via HPRA Pharmacovigilance, Earlsfort Terrace, IRL – Dublin 2; Tel: +353 1 6764971; Fax: +353 1 6762517. Website: www.hpra.ie; E-mail:medsafety@hpra.ie.
In section 10 Date of revision of the text, the date has changed to "June 2015"
Updated on 10 July 2015
Reasons for updating
- Change to date of revision
- Addition of information on reporting a side effect.
Updated on 25 July 2014
Reasons for updating
- Change to date of revision
- Removal/change of distributor
Updated on 20 June 2011
Reasons for updating
- Change to section 6.5 - Nature and contents of container
- Change to section 10 - Date of revision of the text
Legal category:Supply through pharmacy only
Free text change information supplied by the pharmaceutical company
In section 10 (Date of revision of the text) the date has changed to "June 2011"
Updated on 25 June 2009
Reasons for updating
- Change due to user-testing of patient information
Updated on 29 August 2007
Reasons for updating
- Change of trade or active ingredient name
- Change to further information section
Updated on 13 August 2007
Reasons for updating
- Change to section 6.5 - Nature and contents of container
Legal category:Supply through pharmacy only
Free text change information supplied by the pharmaceutical company
Updated on 18 August 2006
Reasons for updating
- Change to section 1 - Name of medicinal product
- Change to section 4.2 - Posology and method of administration
- Change to section 4.3 - Contraindications
- Change to section 4.4 - Special warnings and precautions for use
- Change to section 6.4 - Special precautions for storage
- Change to section 9 - Date of renewal of authorisation
- Change to section 10 - Date of revision of the text
Legal category:Supply through pharmacy only
Free text change information supplied by the pharmaceutical company
Updated on 07 September 2004
Reasons for updating
- New PIL for medicines.ie
Updated on 27 June 2003
Reasons for updating
- Change to section 6.4 - Special precautions for storage
Legal category:Supply through pharmacy only
Updated on 12 June 2003
Reasons for updating
- New SPC for medicines.ie
Legal category:Supply through pharmacy only